Literature DB >> 11879183

Bisphenol A diglycidyl ether induces apoptosis in tumour cells independently of peroxisome proliferator-activated receptor-gamma, in caspase-dependent and -independent manners.

Sebastian Fehlberg1, Stefan Trautwein, Alexandra Göke, Rüdiger Göke.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are nuclear transcription factors which are involved in many biological processes, such as regulation of cell differentiation, lipid metabolism, inflammation and cell death. PPARs consist of three families, PPAR-alpha, PPAR-delta and PPAR-gamma. Bisphenol A diglycidyl ether (BADGE) has been described as a pure antagonist of PPAR-gamma. However, recent data also revealed PPAR-gamma-agonistic activities of BADGE. Here we show that BADGE kills transformed cells by apoptosis and promotes the cytotoxic effects of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and indomethacin. The cytotoxic effect of BADGE does not require PPAR-gamma expression and is mediated in caspase-dependent and caspase-independent manners.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11879183      PMCID: PMC1222420          DOI: 10.1042/0264-6021:3620573

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells.

Authors:  V A Fadok; D J Laszlo; P W Noble; L Weinstein; D W Riches; P M Henson
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

Review 2.  Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins.

Authors:  P Raynal; H B Pollard
Journal:  Biochim Biophys Acta       Date:  1994-04-05

3.  PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation.

Authors:  A Chawla; Y Barak; L Nagy; D Liao; P Tontonoz; R M Evans
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

4.  Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation.

Authors:  S S Palakurthi; H Aktas; L M Grubissich; R M Mortensen; J A Halperin
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

5.  Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups.

Authors:  J Dachary-Prigent; J M Freyssinet; J M Pasquet; J C Carron; A T Nurden
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

6.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.

Authors:  P Tontonoz; E Hu; R A Graves; A I Budavari; B M Spiegelman
Journal:  Genes Dev       Date:  1994-05-15       Impact factor: 11.361

7.  Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor.

Authors:  K L Gearing; M Göttlicher; M Teboul; E Widmark; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

8.  PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene.

Authors:  P Tontonoz; E Hu; J Devine; E G Beale; B M Spiegelman
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

9.  Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.

Authors:  G Koopman; C P Reutelingsperger; G A Kuijten; R M Keehnen; S T Pals; M H van Oers
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

10.  A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1).

Authors:  A Cossarizza; M Baccarani-Contri; G Kalashnikova; C Franceschi
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

View more
  9 in total

1.  Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats.

Authors:  Sajay B Churi; Omar S Abdel-Aleem; Kiranjeet K Tumber; Heather Scuderi-Porter; Bradley K Taylor
Journal:  J Pain       Date:  2008-04-03       Impact factor: 5.820

2.  Bisphenol A diglycidyl ether-induced apoptosis involves Bax/Bid-dependent mitochondrial release of apoptosis-inducing factor (AIF), cytochrome c and Smac/DIABLO.

Authors:  Sebastian Fehlberg; Cornelia M Gregel; Alexandra Göke; Rüdiger Göke
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

3.  Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.

Authors:  J Morgenweck; O S Abdel-Aleem; K C McNamara; R R Donahue; M Z Badr; B K Taylor
Journal:  Neuropharmacology       Date:  2009-11-03       Impact factor: 5.250

4.  Dynamin-related Protein 1 Inhibition Mitigates Bisphenol A-mediated Alterations in Mitochondrial Dynamics and Neural Stem Cell Proliferation and Differentiation.

Authors:  Swati Agarwal; Anuradha Yadav; Shashi Kant Tiwari; Brashket Seth; Lalit Kumar Singh Chauhan; Puneet Khare; Ratan Singh Ray; Rajnish Kumar Chaturvedi
Journal:  J Biol Chem       Date:  2016-06-01       Impact factor: 5.157

5.  PPARγ antagonist attenuates mouse immune-mediated bone marrow failure by inhibition of T cell function.

Authors:  Kazuya Sato; Xingmin Feng; Jichun Chen; Jungang Li; Pawel Muranski; Marie J Desierto; Keyvan Keyvanfar; Daniela Malide; Sachiko Kajigaya; Neal S Young
Journal:  Haematologica       Date:  2015-11-20       Impact factor: 9.941

6.  Bisphenol A diglycidyl ether induces adipogenic differentiation of multipotent stromal stem cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.

Authors:  Raquel Chamorro-García; Séverine Kirchner; Xia Li; Amanda Janesick; Stephanie C Casey; Connie Chow; Bruce Blumberg
Journal:  Environ Health Perspect       Date:  2012-05-25       Impact factor: 9.031

7.  Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types.

Authors:  Jack D Burton; David M Goldenberg; Rosalyn D Blumenthal
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

8.  Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.

Authors:  Gabriela Magenta; Ximena Borenstein; Romina Rolando; María Adela Jasnis
Journal:  BMC Cancer       Date:  2008-02-08       Impact factor: 4.430

9.  PPARgamma Inhibitors as Novel Tubulin-Targeting Agents.

Authors:  Katherine L Schaefer
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.